Melanie is a Doctor of Pharmacy and a freelance medical writer with a strong foundation in medical communications. A graduate of Larkin University, she gained experience in pharmacovigilance and medical affairs at AstraZeneca before joining Ashfield MedComms. Her background is rooted in clinical research and project management.
She demonstrates a keen interest in the broader pharmaceutical landscape by following industry leaders like Pfizer and Johnson & Johnson. This suggests a passion for tracking key innovations and breakthroughs in medicine that extends beyond her direct work.
She co-authored research on the specific mechanisms of opioid toxicity related to Cytochrome P450 drug-drug interactions.